Valuation Actuate Therapeutics, Inc.

Stocks

Delayed Nasdaq 18:15:28 22/10/2026 BST			5-day change	1st Jan Change
0.4970 ^USD	-11.60%		-3.94%	-92.15%

10-07	Top Premarket Decliners	MT
09-09	Actuate Therapeutics Announces Promising Preclinical Data Showing Synergistic Activity of Elraglusib in Combination with Ras Inhibitors Zoldonrasib and Daraxonrasib	CI

Data adjusted to current consolidation scope

Fiscal Period: December	2024	2025	2026	2027	2028
Market Cap ¹	155.5	142.2	13.5	-	-
Change	-	-8.5%	-90.51%	-	-
Enterprise Value (EV)	155.5	142.2	13.5	13.5	13.5
Change	-	-8.5%	-90.51%	0%	0%
P/E	-	-	-	-	-
PBR	-	-	-	-	-
PEG	-	-	-	-	-
Capitalization / Revenue	-	-	-	-	-
EV / Revenue	-	-	-	-	-
EV / EBITDA	-	-	-	-	-
EV / EBIT	-0x	-0x	-0.62x	-0.51x	-0.43x
EV / FCF	-	-0x	-0.64x	-0.51x	-0.43x
FCF Yield	-	-15.6%	-157%	-198%	-231%
Dividend per Share ²	-	-	-	-	-
Rate of return	-	-	-	-	-
EPS ²	-	-	-	-	-
Distribution rate	-	-	-	-	-
Net sales ¹	-	-	-	-	-
EBITDA	-	-	-	-	-
EBIT ¹	-25.16	-22.5	-21.82	-26.61	-31.56
Net income	-	-	-	-	-
Net Debt	-	-	-	-	-
Reference price ²	7.9600	6.1200	0.5622	0.5622	0.5622
Nbr of stocks (in thousands)	19,532	23,243	24,014	-	-
Announcement Date	13/03/25	26/03/26	-	-	-

¹USD in Million²USD

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
ACTUATE THERAPEUTICS, INC.	-	-	-	-	13.5M
WUXI APPTEC CO., LTD.	19.17x	6.81x	13.53x	1.55%	66.22B
ARGENX SE	30.52x	8.19x	25.9x	0.05%	55.2B
LONZA GROUP AG	36.31x	6.45x	19.27x	0.89%	52.79B
IQVIA HOLDINGS INC.	35.25x	3.42x	14.76x	-.--%	45.53B
BEONE MEDICINES AG	50.87x	5.89x	32.33x	-.--%	43.94B
REVOLUTION MEDICINES, INC.	-20.15x	197.1x	-21.43x	-.--%	41.64B
CELLTRION, INC.	29.51x	8.36x	21.63x	0.36%	34B
WUXI BIOLOGICS (CAYMAN) INC.	29.85x	6.32x	16.4x	-.--%	25.84B
GENMAB A/S	32.16x	5.92x	19.93x	-.--%	23.51B
Average	27.06x	27.61x	15.81x	0.32%	38.87B
Weighted average by Cap.	26.77x	26.89x	15.88x	0.42%